Introducing a purpose-built product for Life Sciences companies in Asia Pacific

Liberty is proud to launch Liberty Remedy for Life Sciences™, a dedicated product for the Life Sciences industry that empowers innovation from lab to market.

Liberty Remedy offers tailored coverage for companies researching and developing pharmaceuticals, biologics, medical devices, complementary medicines, diagnostics and clinical trials; from early-stage research through to global commercial manufacturing and distribution.

Drawing on Liberty’s experience in selectively writing Life Sciences risks, Liberty Remedy is an industry-specific policy designed to reduce unnecessary exclusions and align with the needs of Life Sciences companies. We’ve also simplified policy language to make it easier for brokers and clients to understand what they're buying.

We know the Life Sciences sector demands technical knowledge that general liability expertise often doesn’t provide. Liberty Remedy addresses the gap in the market by offering purpose-built coverage that's broader and clearer, and backed by our deep technical expertise.

Liberty Remedy builds on our years of underwriting experience and is supported by our specialist team of liability risk engineers based across China, Hong Kong, Singapore and Australia. Clients will also benefit from our global Life Sciences network which spans the US, Europe and Canada. That's a significant advantage in a sector that’s very technical and globally interconnected.

For more information about Liberty Remedy for Life Sciences™ or to contact an underwriter, please visit our Life Sciences page.